Year 2022 / Volume 114 / Number 1
Letter
Autoimmune hepatitis triggered by COVID-19

64-65

DOI: 10.17235/reed.2021.8045/2021

Cristina Montón Rodríguez, Pablo Navarro Cortés, Paloma Lluch García, Miguel Mínguez Pérez,

Abstract
We present the case of a 60-year-old female with no drug allergies or toxic habits, with hypothyroidism, and receiving treatment with levothyroxine. She was admitted in February 2021 and presented with choluria of 72 hours duration; there were no abdominal or respiratory clinical symptoms, and no related fever. Medical examination findings included mucocutaneous jaundice and a recorded oxygen saturation of 97 % in ambient air. There was a notable pattern of cytolysis compatible with acute hepatitis, and no history hepatotoxic drugs. Screening was performed for acute hepatitis in addition to serology testing, determination of autoantibodies and immunoglobulins, a PCR test for COVID, and a radiologic study.
Share Button
New comment
Comments
No comments for this article
References
1. Jothimani D, Venugopal R, Forhad Abedin M, et al. COVID 19 and the Liver. J Hepatol 2020;73(5):1231-40.
2. Garrido I, Liberal R, Macedo G. Review article: COVID‐19 and liver disease—what we know on 1st May 2020. Aliment Pharmacol Ther 2020;52(2):267-75. DOI: 10,111/apt15813
3. Ampuero J, Sánchez Y, Garcia-Lozano MR, et al. Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis. Rev Esp Enferm Dig 2021;113(2):125-35.
4. Rajendiran G, Cowman B, Erickson K, et al. Autoimmune Hepatitis Associated with COVID-19 Infection - A Diagnostic and Therapeutic Dilemma. S D Med 2020;73(11):528-32.
5. Signh B, Kaur P, Maroules M. Autoinmmne hepatitis – Primary Biliary Cholangitis Overlap Syndrome Triggered by Covid 19. Eur J Case Rep Intern Med 2021;8(3):002264. DOI: 10.12890/2021_002264
Related articles

Letter

Autoimmune hepatitis after SARS-C¬¬oV-2 vaccination

DOI: 10.17235/reed.2023.9579/2023

Digestive Diseases Image

Endosonographic and ERCP findings in COVID-19 critical illness cholangiopathy

DOI: 10.17235/reed.2022.9218/2022

Letter

Infection with SARS-CoV-2 as a potential achalasia trigger

DOI: 10.17235/reed.2022.8975/2022

Digestive Diseases Image

Acute respiratory failure secondary to megaesophagus: think beyond COVID-19

DOI: 10.17235/reed.2022.8847/2022

Letter

SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?

DOI: 10.17235/reed.2022.8820/2022

Letter

Surgical acute abdomen and COVID-19 vaccination

DOI: 10.17235/reed.2022.8721/2022

Letter

AMA-positive hepatitis induced by the SARS-CoV-2 vaccine.

DOI: 10.17235/reed.2022.8533/2021

Letter

A case of COVID-19 with concomitant infection with hepatitis A

DOI: 10.17235/reed.2021.8372/2021

Letter

COVID-19 and aorto-enteric fistula

DOI: 10.17235/reed.2021.8272/2021

Digestive Diseases Image

Portal thrombosis in a patient with SARS-CoV-2 infection

DOI: 10.17235/reed.2021.8099/2021

Letter

Pneumoperitoneum and COVID-19. A causal association?

DOI: 10.17235/reed.2021.7877/2021

Letter

COVID-19 and the liver: the chicken or the egg dilemma

DOI: 10.17235/reed.2021.7861/2021

Letter

Acute pancreatitis related to SARS-CoV-2 infection. Disclaimer

DOI: 10.17235/reed.2021.7853/2021

Letter

Pancreatic injury and acute pancreatitis in COVID-19 patients

DOI: 10.17235/reed.2021.7807/2021

Editorial

Leading in turbulent times with the aim to serve

DOI: 10.17235/reed.2020.7684/2020

Letter

Pancreatic injury in COVID-19: pathogenesis and challenges

DOI: 10.17235/reed.2020.7541/2020

Letter

SARS-CoV-2 and acute pancreatitis: a new etiological agent?

DOI: 10.17235/reed.2020.7481/2020

Letter

Latin American authorship in scientific production on COVID-19

DOI: 10.17235/reed.2020.7432/2020

Letter

COVID-19. Immunothrombosis and the gastrointestinal tract

DOI: 10.17235/reed.2020.7292/2020

Letter

Acute hepatitis due to olmesartan: an uncommon entity

DOI: 10.17235/reed.2020.7236/2020

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Rapid reviews

COVID-19, coronavirus, SARS-CoV-2 and the small bowel

DOI: 10.17235/reed.2020.7137/2020

Letter to the Editor

Autoimmune hepatitis as a complication of common variable immunodeficiency

DOI: 10.17235/reed.2018.5280/2017

Case Report

The clinical extremes of autoimmune cholangitis

DOI: 10.17235/reed.2017.4167/2015

Citation tools
Montón Rodríguez C, Navarro Cortés P, Lluch García P, Mínguez Pérez M. Autoimmune hepatitis triggered by COVID-19. 8045/2021


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1634 visits.
This article has been downloaded 389 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 16/04/2021

Accepted: 08/05/2021

Online First: 21/05/2021

Published: 10/01/2022

Article revision time: 16 days

Article Online First time: 35 days

Article editing time: 269 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology